163 related articles for article (PubMed ID: 3879159)
1. In vitro antibacterial activity of Sch 34343 and its stability to beta-lactamases and renal dehydropeptidase 1.
Matsuda K; Sasaki K; Inoue K; Kondo H; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1985 Nov; 28(5):684-8. PubMed ID: 3879159
[TBL] [Abstract][Full Text] [Related]
2. In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():99-109. PubMed ID: 3875606
[TBL] [Abstract][Full Text] [Related]
3. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
Shannon K; King A; Phillips I
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of Sch 34343 against Gram-negative bacteria producing characterized beta-lactamases.
Dornbusch K; Frolander F; Cacciapuoti AF; Naples L; Hare RS; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():85-97. PubMed ID: 3897175
[TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.
Mitsuhashi S
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():53-64. PubMed ID: 6607914
[TBL] [Abstract][Full Text] [Related]
6. Sch 34343, in-vitro antibacterial activity and beta-lactamase stability.
Stobberingh EE; Houben AW; van Boven CP
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():73-83. PubMed ID: 3875605
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.
Minamimura M; Taniyama Y; Inoue E; Mitsuhashi S
Antimicrob Agents Chemother; 1993 Jul; 37(7):1547-51. PubMed ID: 8363389
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the in-vitro antibacterial activity of Sch 34343.
Adam C; Naples L; Weiss W; Sabatelli F; Hare R; Loebenberg D; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():39-56. PubMed ID: 3875604
[TBL] [Abstract][Full Text] [Related]
10. beta-Lactamase susceptibility and comparative activity of Sch 34343 and other beta-lactams for non-fermenters, Neisseria spp. and beta-lactamase-positive Enterobacteriaceae.
Mouton RP; Mulders SL; van Gestel MH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():111-7. PubMed ID: 3928576
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
Nakagawa S; Hashizume T; Matsuda K; Sanada M; Okamoto O; Fukatsu H; Tanaka N
Antimicrob Agents Chemother; 1993 Dec; 37(12):2756-9. PubMed ID: 8109950
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
Matsumura N; Minami S; Mitsuhashi S
J Antimicrob Chemother; 1997 Jan; 39(1):31-4. PubMed ID: 9044025
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
Dornbusch K; Adamsson L; Gezelius L; Hallander H
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():113-21. PubMed ID: 6460739
[No Abstract] [Full Text] [Related]
15. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
Medeiros AA; Hare R; Papa E; Adam C; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
[TBL] [Abstract][Full Text] [Related]
16. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Hikida M; Itahashi K; Igarashi A; Shiba T; Kitamura M
Antimicrob Agents Chemother; 1999 Aug; 43(8):2010-6. PubMed ID: 10428928
[TBL] [Abstract][Full Text] [Related]
17. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
Edwards JR
New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
[TBL] [Abstract][Full Text] [Related]
18. Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamases.
Phillips I; King A; Shannon K; Warren C
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():25-30. PubMed ID: 6977532
[No Abstract] [Full Text] [Related]
19. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
Neu HC; Chin NX; Neu NM
Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
Neu HC; Chin NX; Labthavikul P
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
